US Patent 6861509 Antibodies to Ret and RetL3
Patent 6861509 was granted and assigned to Biogen on March, 2005 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 6861509 Antibodies to Ret and RetL3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
